Glen Mills, PA, United States of America

Joel R Courter

This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Incyte Corporation, Bryn Mawr College, Columbia University. Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joel R Courter. Retrieved from https://idiyas.com/inventor/joel-r-courter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 8.5

ph-index = 6

Forward Citations = 110(Granted Patents)

Location History:

Philadelphia, PA (US) (2016)
Wilmington, DE (US) (2018 - 2020)
Glen Mills, PA (US) (2016 - 2022)

Company Filing History:

Dana-Farber-Cancer Institute Inc.

patents

5. 1 out of 3,798

Johns Hopkins University

patents

6. 1 out of 2,655

University of Pennsylvania

patents

7. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2016-2022

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11247992 - Cyclopropylamines as LSD1 inhibitors (2022-02-15),

2. 10556908 - Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors (2020-02-11),

3. 10300051 - Cyclopropylamines as LSD1 inhibitors (2019-05-28),

4. 10174030 - Cyclopropylamines as LSD1 inhibitors (2019-01-08),

5. 10112950 - Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors (2018-10-30),

6. 9776963 - Small molecule CD4 mimetics and uses thereof (2017-10-03),

7. 9695180 - Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors (2017-07-04),

8. 9493442 - Cyclopropylamines as LSD1 inhibitors (2016-11-15),

9. 9403763 - CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof (2016-08-02),

Title: **The Innovative Mind of Joel R. Courter**

Introduction

Joel R. Courter, based in Glen Mills, Pennsylvania, is an accomplished inventor with a remarkable track record of nine patents. His contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer, demonstrate his innovative spirit and dedication to improving healthcare.

Latest Patents

Among his latest patents, Courter has developed cyclopropylamine derivatives that function as LSD1 inhibitors. These compounds are aimed at treating diseases such as cancer, showcasing his focus on impactful medical innovations. Additionally, he has patented substituted imidazo[1,2-a]pyrazines, which are also LSD1 inhibitors and are useful in the treatment of various cancers. Both inventions reflect his commitment to addressing critical health challenges through innovative solutions.

Career Highlights

Throughout his career, Joel R. Courter has held various positions in notable companies, including Incyte Corporation. His work there has significantly contributed to advancements in medicinal chemistry and cancer therapeutics, solidifying his reputation in the industry.

Collaborations

In his journey as an inventor, Courter has collaborated with talented individuals such as Liangxing Wu and Chunhong He. These partnerships have fostered an environment of creativity and knowledge exchange, leading to significant advancements in their shared field of research.

Conclusion

Joel R. Courter's impressive portfolio of patents and collaborations marks him as a key figure in the world of pharmaceutical innovation. With his continued efforts, he not only advances scientific research but also plays a crucial role in the development of new treatments that could potentially save lives.

Profile summary based on public USPTO records.